1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global HER2 Target Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for HER2 Target Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for HER2 Target Drugs by Country/Region, 2018, 2022 & 2029
2.2 HER2 Target Drugs Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Small Molecule Chemicals
2.2.3 Antibody Drug Conjugate
2.3 HER2 Target Drugs Sales by Type
2.3.1 Global HER2 Target Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global HER2 Target Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global HER2 Target Drugs Sale Price by Type (2018-2023)
2.4 HER2 Target Drugs Segment by Application
2.4.1 Breast Cancer
2.4.2 Colorectal Cancer
2.4.3 Stomach Cancer
2.4.4 Other
2.5 HER2 Target Drugs Sales by Application
2.5.1 Global HER2 Target Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global HER2 Target Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global HER2 Target Drugs Sale Price by Application (2018-2023)
3 Global HER2 Target Drugs by Company
3.1 Global HER2 Target Drugs Breakdown Data by Company
3.1.1 Global HER2 Target Drugs Annual Sales by Company (2018-2023)
3.1.2 Global HER2 Target Drugs Sales Market Share by Company (2018-2023)
3.2 Global HER2 Target Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global HER2 Target Drugs Revenue by Company (2018-2023)
3.2.2 Global HER2 Target Drugs Revenue Market Share by Company (2018-2023)
3.3 Global HER2 Target Drugs Sale Price by Company
3.4 Key Manufacturers HER2 Target Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers HER2 Target Drugs Product Location Distribution
3.4.2 Players HER2 Target Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for HER2 Target Drugs by Geographic Region
4.1 World Historic HER2 Target Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global HER2 Target Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global HER2 Target Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic HER2 Target Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global HER2 Target Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global HER2 Target Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas HER2 Target Drugs Sales Growth
4.4 APAC HER2 Target Drugs Sales Growth
4.5 Europe HER2 Target Drugs Sales Growth
4.6 Middle East & Africa HER2 Target Drugs Sales Growth
5 Americas
5.1 Americas HER2 Target Drugs Sales by Country
5.1.1 Americas HER2 Target Drugs Sales by Country (2018-2023)
5.1.2 Americas HER2 Target Drugs Revenue by Country (2018-2023)
5.2 Americas HER2 Target Drugs Sales by Type
5.3 Americas HER2 Target Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HER2 Target Drugs Sales by Region
6.1.1 APAC HER2 Target Drugs Sales by Region (2018-2023)
6.1.2 APAC HER2 Target Drugs Revenue by Region (2018-2023)
6.2 APAC HER2 Target Drugs Sales by Type
6.3 APAC HER2 Target Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe HER2 Target Drugs by Country
7.1.1 Europe HER2 Target Drugs Sales by Country (2018-2023)
7.1.2 Europe HER2 Target Drugs Revenue by Country (2018-2023)
7.2 Europe HER2 Target Drugs Sales by Type
7.3 Europe HER2 Target Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa HER2 Target Drugs by Country
8.1.1 Middle East & Africa HER2 Target Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa HER2 Target Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa HER2 Target Drugs Sales by Type
8.3 Middle East & Africa HER2 Target Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of HER2 Target Drugs
10.3 Manufacturing Process Analysis of HER2 Target Drugs
10.4 Industry Chain Structure of HER2 Target Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 HER2 Target Drugs Distributors
11.3 HER2 Target Drugs Customer
12 World Forecast Review for HER2 Target Drugs by Geographic Region
12.1 Global HER2 Target Drugs Market Size Forecast by Region
12.1.1 Global HER2 Target Drugs Forecast by Region (2024-2029)
12.1.2 Global HER2 Target Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global HER2 Target Drugs Forecast by Type
12.7 Global HER2 Target Drugs Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche HER2 Target Drugs Product Portfolios and Specifications
13.1.3 Roche HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK HER2 Target Drugs Product Portfolios and Specifications
13.2.3 GSK HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Boehringer Digelheim
13.3.1 Boehringer Digelheim Company Information
13.3.2 Boehringer Digelheim HER2 Target Drugs Product Portfolios and Specifications
13.3.3 Boehringer Digelheim HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Boehringer Digelheim Main Business Overview
13.3.5 Boehringer Digelheim Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer HER2 Target Drugs Product Portfolios and Specifications
13.4.3 Pfizer HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca HER2 Target Drugs Product Portfolios and Specifications
13.5.3 AstraZeneca HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Seagen
13.6.1 Seagen Company Information
13.6.2 Seagen HER2 Target Drugs Product Portfolios and Specifications
13.6.3 Seagen HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Seagen Main Business Overview
13.6.5 Seagen Latest Developments
13.7 MacroGenics
13.7.1 MacroGenics Company Information
13.7.2 MacroGenics HER2 Target Drugs Product Portfolios and Specifications
13.7.3 MacroGenics HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 MacroGenics Main Business Overview
13.7.5 MacroGenics Latest Developments
13.8 Takeda
13.8.1 Takeda Company Information
13.8.2 Takeda HER2 Target Drugs Product Portfolios and Specifications
13.8.3 Takeda HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Takeda Main Business Overview
13.8.5 Takeda Latest Developments
13.9 Daiichi Sankyo
13.9.1 Daiichi Sankyo Company Information
13.9.2 Daiichi Sankyo HER2 Target Drugs Product Portfolios and Specifications
13.9.3 Daiichi Sankyo HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Daiichi Sankyo Main Business Overview
13.9.5 Daiichi Sankyo Latest Developments
13.10 Novartis AG
13.10.1 Novartis AG Company Information
13.10.2 Novartis AG HER2 Target Drugs Product Portfolios and Specifications
13.10.3 Novartis AG HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Novartis AG Main Business Overview
13.10.5 Novartis AG Latest Developments
13.11 RemeGen
13.11.1 RemeGen Company Information
13.11.2 RemeGen HER2 Target Drugs Product Portfolios and Specifications
13.11.3 RemeGen HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 RemeGen Main Business Overview
13.11.5 RemeGen Latest Developments
13.12 Sunshine Guojian
13.12.1 Sunshine Guojian Company Information
13.12.2 Sunshine Guojian HER2 Target Drugs Product Portfolios and Specifications
13.12.3 Sunshine Guojian HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Sunshine Guojian Main Business Overview
13.12.5 Sunshine Guojian Latest Developments
13.13 Hengrui Medicine
13.13.1 Hengrui Medicine Company Information
13.13.2 Hengrui Medicine HER2 Target Drugs Product Portfolios and Specifications
13.13.3 Hengrui Medicine HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Hengrui Medicine Main Business Overview
13.13.5 Hengrui Medicine Latest Developments
14 Research Findings and Conclusion
